A detailed history of Patten Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Patten Group, Inc. holds 1,590 shares of ABBV stock, worth $284,928. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,590
Previous 1,731 8.15%
Holding current value
$284,928
Previous $296,000 5.74%
% of portfolio
0.07%
Previous 0.07%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$163.84 - $199.33 $23,101 - $28,105
-141 Reduced 8.15%
1,590 $313,000
Q1 2024

Apr 17, 2024

SELL
$159.82 - $182.1 $13,105 - $14,932
-82 Reduced 4.52%
1,731 $315,000
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $34,400 - $38,742
-250 Reduced 12.12%
1,813 $280,000
Q3 2023

Oct 12, 2023

BUY
$133.59 - $154.65 $64,390 - $74,541
482 Added 30.49%
2,063 $307,000
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $1,325 - $1,649
-10 Reduced 0.63%
1,581 $213,000
Q1 2023

Apr 06, 2023

BUY
$144.61 - $166.54 $43,383 - $49,962
300 Added 23.24%
1,591 $253,000
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $178,558 - $214,138
1,291 New
1,291 $208,000
Q1 2022

Apr 28, 2022

BUY
$131.98 - $163.75 $190,843 - $236,782
1,446 New
1,446 $234,000
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $198,095 - $233,148
-2,568 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $14,090 - $17,377
-181 Reduced 6.58%
2,568 $237,000
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $10,224 - $11,366
-115 Reduced 4.02%
2,749 $260,000
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $4,489 - $5,311
50 Added 1.78%
2,864 $265,000
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $736 - $985
8 Added 0.29%
2,814 $266,000
Q4 2017

Feb 02, 2018

BUY
$89.56 - $98.21 $447 - $491
5 Added 0.18%
2,806 $271,000
Q3 2017

Dec 13, 2017

BUY
$69.85 - $89.22 $136,766 - $174,692
1,958 Added 232.27%
2,801 $249,000
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $138,093 - $176,387
-1,977 Reduced 70.11%
843 $249,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,820
2,820 $200,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Patten Group, Inc. Portfolio

Follow Patten Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.